CVRdatabase
Menu

Eurofins Genomics Denmark A/S

Public limited companyCVR 10048818GaltenActive

Eurofins Genomics Denmark A/S is a public limited company, based in Galten, active in research and experimental development on natural sciences and engineering, founded in 2000. The company made a loss in both 2024 and 2025, most recently DKK 8.6m. Operations are spread over 4 production units. With 66 employees, the company is about 13 times larger than the industry median.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 43.6m+18.5% vs. 2024
Net profit−DKK 8.6m+32.5% vs. 2024
EquityDKK 14.2m+442.9% vs. 2024
Employees66latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 18% (2024 → 2025), to DKK 43.6m.
  • The loss got smaller: from DKK 12.8m to DKK 8.6m (2024 → 2025).
  • Equity turned positive again: DKK 14.2m (2024 → 2025).

Employees

  • 3 fewer employees than a year earlier: 66 (08/2026) against 69 (08/2025).

Management and owners, last 24 months

  • New owners registered: Eurofins Genomics LUX Holding SARL (01/05/2025).
  • No longer registered as owner: Eurofins Genomics Holding Denmark A/S (01/05/2025).

Registrations, last 24 months

  • 16/05/2025: Name changed from Eurofins Genomics Europe AgriGenomics Products & Services A/S to Eurofins Genomics Denmark A/S
  • 01/05/2025: Merger registered in CVR
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 30m−DKK 20m−DKK 10mDKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50m202020212022202320242025
EquityNet profit
Financial figures for Eurofins Genomics Denmark A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit40,932104,25327,20617,33136,82343,634+18.5%
Operating profit (EBIT)15,10442,386−14,872−23,101−9,084−8,464+6.8%
Profit before tax14,78841,505−16,474−26,592−14,525−11,080+23.7%
Net profit11,53432,351−12,918−20,742−12,812−8,644+32.5%
Total assets105,845123,92177,042134,500175,330143,100−18.4%
Equity23,00349,85515,93617,796−4,14414,212+442.9%
Liabilities82,84274,06661,106116,130178,774128,615−28.1%
Cash and cash equivalents3573,2131,612433–1,305–
Average number of employees4210168566264+3.2%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 20mDKK 40mDKK 60mDKK 80mDKK 100m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 4 years in a row

    Net result has been negative in 2022–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

  • Low equity ratio

    Equity makes up 10% of total assets in 2025.

    How is this calculated?

    Equity ÷ total assets is below 10% in the latest annual report. Banks, insurers and some industries naturally have a low ratio.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Eurofins Genomics Denmark A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202503/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202403/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202327/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202208/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202119/05/2022The companyPDFXBRL
202001/01/2020 – 31/12/202014/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
01020304050607009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 43.6mNo. 37 of 421
Better than 91% of the companies in the industry
EquityDKK 14.2mNo. 123 of 431
Better than 72% of the companies in the industry
Number of employees66No. 30 of 431
Better than 93% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 50–199 employees4,467 companies in the comparison
No. 2,077of 4,412
Better than 53%
No. 2,548of 4,466
Better than 43%
Same industry and 50–199 employees27 companies in the comparison
No. 17of 26
Better than 36%
No. 24of 27
Better than 12%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 1,643of 24,791
Better than 93%
No. 5,427of 24,909
Better than 78%
All companies of type A/S18,025 companies in the comparison
No. 3,283of 17,786
Better than 82%
No. 7,404of 18,024
Better than 59%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Eurofins Genomics Denmark A/SDKK 43.6m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Eurofins Genomics Denmark A/S−DKK 8.6m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Eurofins Genomics Denmark A/SDKK 14.2m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Eurofins Genomics Denmark A/S66
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Eurofins Genomics LUX Holding SARL100%
Eurofins Genomics Denmark A/S

Management

4 active registrations

Executive management

Executive management at Eurofins Genomics Denmark A/S
NameRoleAppointed
Jacob Sickmann RansborgCEO11/06/2018

Board of directors

Board of directors at Eurofins Genomics Denmark A/S
NameRoleAppointed
Svend Aage LindeChair of the board20/02/2013
Jacob Sickmann RansborgBoard member27/05/2021
Ulrich August Werner KühleBoard member01/03/2024
Founders
Torben Falck Ørntoft, Thomas Thykjær Andersen, Mogens Kruhøffer, Østjysk Innovation A/S
Former management (21)
Former management at Eurofins Genomics Denmark A/S
NameRoleAppointedResigned
Torben Falck ØrntoftDirector01/11/200020/05/2009
Jørn Renz EnggaardBoard member01/11/200001/12/2004
Mogens KruhøfferBoard member01/11/200018/11/2003
Claus ThorsenBoard member13/03/200209/02/2007
Villy HelleskovBoard member13/03/200220/02/2013
Jørgen Winther PedersenBoard member18/11/200320/02/2013
Arne Josefsen RolighedBoard member18/11/200311/09/2007
Niels Stampe RüdigerBoard member20/05/200920/02/2013
Carsten Kultoft LorentsenBoard member20/05/200924/09/2010
Brian SørensenCEO20/05/200901/09/2013
Kurt Hedegaard CarstensenBoard member21/03/201120/02/2013
Torben Falck ØrntoftBoard member20/02/201327/05/2015
Lars Christian CaspersenBoard member20/02/201313/08/2015
Bruno Francis Claude PoddevinBoard member20/02/201317/07/2020
Morten MelbyeCEO01/09/201331/12/2016
Thomas GjelsnesBoard member13/08/201501/01/2018
Morten MelbyeBoard member30/05/201631/12/2016
Daniel Schougaard LanghoffCEO01/01/201711/06/2018
Stefánia PcolováBoard member26/01/201827/05/2021
Michael HademBoard member17/07/202001/07/2023
Sonja Maria WiedemannBoard member01/07/202329/02/2024

Signing rule: Selskabet tegnes af den samlede bestyrelse eller af bestyrelsesformanden i forening med  direktøren eller et bestyrelsesmedlem.

Address and production units

4 active production units

Smedeskovvej 38
8464 Galten

Skanderborg Municipality · Postcode 8464

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
Eurofins Genomics Denmark A/SSmedeskovvej 38, 8464 Galten361020757171
Eurofins Genomics Denmark A/SSmedeskovvej 55, 8464 Galten301031229215
Eurofins Genomics Europe Genotyping ScreeningBrendstrupgårdsvej 21A, 8200 Aarhus N181026189019
Eurofins Genomics Europe Genotyping A/SBrendstrupgårdsvej 23, 8200 Aarhus N11026559126

Purpose

Selskabets formål er kontraktforskning, laboratoriemæssig service og handel med knowhow og laboratorieydelser.

The purpose is quoted from the register in Danish.

Changes year by year

70 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20256 changesaccounts 1 · name 1 · ownership 2 · merger 1 · industry 1
  • Annual report for 2024 published
  • Name changed from Eurofins Genomics Europe AgriGenomics Products & Services A/S to Eurofins Genomics Denmark A/S
  • Eurofins Genomics LUX Holding SARL registered as owner (100%)
  • EUROFINS GENOMICS HOLDING DENMARK A/S is no longer registered as owner
  • Merger registered in CVR
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20243 changesaccounts 1 · management 2
  • Annual report for 2023 published
  • Ulrich August Werner Kühle appointed board member
  • Sonja Maria Wiedemann stepped down as board member
20234 changesmanagement 2 · accounts 1 · name 1
  • Sonja Maria Wiedemann appointed board member
  • Michael Hadem stepped down as board member
  • Annual report for 2022 published
  • Name changed from Eurofins Genomics Europe Genotyping A/S to Eurofins Genomics Europe AgriGenomics Products & Services A/S
20221 changeaccounts 1
  • Annual report for 2021 published
20213 changesaccounts 1 · management 2
  • Annual report for 2020 published
  • Jacob Sickmann Ransborg appointed board member
  • Stefánia Pcolová stepped down as board member
20204 changesmanagement 2 · address 2
  • Michael Hadem appointed board member
  • Bruno Francis Claude Poddevin stepped down as board member
  • Moved to Smedeskovvej 38, 8464 Galten
  • Moved to Palle Juul-Jensens Boulevard 82, 8200 Aarhus N
20191 changename 1
  • Name changed from AROS APPLIED BIOTECHNOLOGY A/S to Eurofins Genomics Europe Genotyping A/S
20185 changesaddress 1 · management 4
  • Moved to Palle Juul-Jensens Boulevard 82, 8200 Aarhus N
  • Jacob Sickmann Ransborg appointed ceo
  • Daniel Schougaard Langhoff stepped down as ceo
  • Stefánia Pcolová appointed board member
  • Thomas Gjelsnes stepped down as board member
20171 changemanagement 1
  • Daniel Schougaard Langhoff appointed ceo
20163 changesmanagement 3
  • Morten Melbye stepped down as board member
  • Morten Melbye stepped down as ceo
  • Morten Melbye appointed board member
20154 changesmanagement 3 · address 1
  • Thomas Gjelsnes appointed board member
  • Lars Christian Caspersen stepped down as board member
  • Torben Falck Ørntoft stepped down as board member
  • Moved to Palle Juul-Jensens Boulevard 82, 8200 Aarhus N
201311 changesmanagement 10 · ownership 1
  • Morten Melbye appointed ceo
  • Brian Sørensen stepped down as ceo
  • Lars Christian Caspersen appointed board member
  • Torben Falck Ørntoft appointed board member
  • Bruno Francis Claude Poddevin appointed board member
  • Svend Aage Linde appointed chair of the board
  • Kurt Hedegaard Carstensen stepped down as board member
  • Niels Stampe Rüdiger stepped down as board member
  • Jørgen Winther Pedersen stepped down as board member
  • Villy Helleskov stepped down as board member
  • EUROFINS GENOMICS HOLDING DENMARK A/S registered as owner (100%)
20111 changemanagement 1
  • Kurt Hedegaard Carstensen appointed board member
20101 changemanagement 1
  • Carsten Kultoft Lorentsen stepped down as board member
20094 changesmanagement 4
  • Brian Sørensen appointed ceo
  • Carsten Kultoft Lorentsen appointed board member
  • Niels Stampe Rüdiger appointed board member
  • Torben Falck Ørntoft stepped down as director
20082 changesaddress 1 · industry 1
  • Moved to Brendstrupgårdsvej 102, 8200 Aarhus N
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
20073 changesmanagement 2 · capital 1
  • Arne Josefsen Rolighed stepped down as board member
  • Share capital changed from 500,000 DKK to 550,000 DKK
  • Claus Thorsen stepped down as board member
20052 changesname 1 · capital 1
  • Name changed from AROS APPLIED BIOTECHNOLOGY ApS to AROS APPLIED BIOTECHNOLOGY A/S
  • Share capital changed from 125,000 DKK to 500,000 DKK
20041 changemanagement 1
  • Jørn Renz Enggaard stepped down as board member
20033 changesmanagement 3
  • Jørgen Winther Pedersen appointed board member
  • Arne Josefsen Rolighed appointed board member
  • Mogens Kruhøffer stepped down as board member
20022 changesmanagement 2
  • Villy Helleskov appointed board member
  • Claus Thorsen appointed board member
20004 changesfounded 1 · management 3
  • Registered as AROS APPLIED BIOTECHNOLOGY ApS
  • Jørn Renz Enggaard appointed board member
  • Torben Falck Ørntoft appointed director
  • Mogens Kruhøffer appointed board member

Related companies

Same industry in Skanderborg

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction